Patent Application
20230297924
The present invention relates to an NADP(H) nanosensor, a cell, a method for isolating genes which code for NADP(H)-dependent enzymes, and the use of an NADP(H) nanosensor.
The use of NADP(H)-dependent enzymes in the chemical industry as a catalyst is disclosed in a large number of examples. Thus, alcohol dehydrogenases, also called oxidoreductases or ketoreductases, are employed for reducing carbonyl groups. In particular, the enantiospecificity and regiospecificity is used for reducing prochiral ketones. Examples of such ketoreductases which serve for the synthesis of useful chemical compounds are the asymmetric reduction of 4-chloroacetoacetate esters (U.S. Pat. Nos. 5,559,030, 5,700,670 and 5,891,685), the reduction of dicarboxylic acids (U.S. Pat. No. 6,399,339), the reduction of tert-butyl-(S)-chloro-5-hydroxy-3-oxohexanoate (U.S. Pat. No. 6,645,746 and WO-A-01/40450), the reduction of pyrrolotriazine-based compounds (US-A-2006/0286646), the reduction of substituted acetophenones (U.S. Pat. No. 6,800,477, US-A-2012/0178142) or the reduction of hydroxythiolanes (WO-A-2005/054491). alpha-haloketones are likewise reduced enzymatically to alpha-haloalcohols. This can also be carried out by isolated enzymes or with whole cells (WO-A-2008/038050). By means of specific alcohol dehydrogenases from Lactobacillus brevis or Thermoanaerobium brokii, the reduction of the 8-chloro-6-oxooctanoic acid alkyl ester to the (R)- or (S)-8-chloro-6-hydroxyoctanoic acid alkyl ester, which is used as the precursor of (R)-α-lipoic acid and (S)-α-lipoic acid respectively, is effected (U.S. Pat. No. 7,157,253). Processes for the preparation of optically active alkanols wherein the preparation of, for example, (1S)-3-methylamino-1-(2-thienyl)-propan-1-ol und (1S)-3-chloro-1-(2-thienyl)-propan-1-ol is carried out by enzymatic reduction of the corresponding ketones are also described (WO-A-2006/094945). A process for preparing 3-hydroxybutyl 3-hydroxybutyrates enantiospecifically by means of ketoreductase or alcohol dehydrogenase is likewise known (US-A-2012/0064611). U.S. Pat. No. 6,645,746 discloses an amino acid sequence from Candida magnoliae which can be used for reducing tert-butyl-(5S)-6-chloro-5-hydroxy-3-oxohexanoate to tert-butyl-(3R,5S)-6-chloro-3,5-dihydroxyhexa-noate with the aid of NADP(H). In the description of this document the enzyme preferably co-expressed with glucose dehydrogenase from Bacillus megaterium is employed, the regeneration of the cofactor NADP(H) being carried out with the aid of glucose dehydrogenase and with glucose as a cosubstrate. WO-A-2004/111083 describes a process for the enantioselective enzymatic reduction of ketones, in particular 2- and 3-oxo acid esters, wherein the reaction is catalysed by an oxidoreductase from Pichia capsulata. WO-A-2005/108593 describes a process for the preparation of 1-butanol in which 2-butanone is reduced with a carbonyl reductase, for example from Candida parapsilosis, and a coenzyme in a two-phase system. EP-A-2 061 880 discloses a process for the NADP(H)-dependent enzymatic preparation of alkenone derivatives from α,β-unsaturated alkynone derivatives, wherein the corresponding reductase is used in purified form or also in the form of the microorganism itself. EP-A-2 087 127 describes a process for the preparation of secol derivatives by enantioselective enzymatic reduction of secodione derivatives using an oxidoreductase/dehydrogenase in the presence of NADP(H).
In addition to the NADP(H)-dependent reduction of ketones and aldehydes, NADP(H)-dependent enzymes, so-called enoate reductases, are also used for enantiospecific reduction of enoates. Thus, Kataoka and colleagues have reported that by using an enoate reductase from Candida macedoniensis together with an NADP(H)-generating glucose dehydrogenase from E. coli ketoisophorone is reduced preparatively to (6R)-levodione (Kataoka, Kotaka, Thiwthong, Wada, Nakamori, and Shimizu, J. Biotechnol., 2004, 114, 1-9).
The use of NADP(H)-dependent enzymes in coupled systems where, for example, the reduction is followed by a cyclisation to the epoxide is furthermore described. The use of (R)- or (S)-selective alcohol dehydrogenases in order to form the corresponding enantiomer and subsequently to achieve the base-induced cyclisation to the particular epoxide is thus described (CA 2 612 407).
Enzymatic provision of NADP(H) is also necessary if monooxygenases are employed, as in the case of the very thoroughly investigated monooxygenase P450 BM3 (CYP102A1) from Bacillus megaterium (Appl. Microbiol. Biotechnol. (2012) 95:357-367). This fatty acid hydroxylase oxidises a wide range of substrates, such as alkanes, alkenes and aromatic hydrocarbons. The monooxygenase catalyses the hydroxylation, but requires the stoichiometric supply of NADP(H).
NADP(H)-dependent enzymes are also employed for reductive amination, such as, for example, of 2-keto acids to the corresponding D-amino acid (WO-A-2006/113085), or of 6-aminocaproic acid from 2-ketopimelate (WO-A-2012/031911).
An overview of the most diverse uses of NADP(H)-dependent enzymes can be found, for example, in Hollmann, Arendsa and Holtmann (Green Chemistry, 2011, 13, 2285-2313), or also the textbook “Industrial Biotransformations” by Liese, Seelbach, and Wandrey (Wiley-VCH Verlag, 2006, ISBN: 3-527-31001-0).
Regardless of the concrete reaction for which NADP(H)-dependent enzymes are to be employed, it is initially a prerequisite to provide suitable enzymes which ensure high conversions and a high stereospecificity. A prerequisite of this in turn is screening for such enzymes, which can be carried out in various ways.
Thus, companies offer enzyme collections, which must then be tested to ascertain whether they convert the desired educt into the desired product, such as, for example, Novozymes A/S located in Bagsverd, Denmark. Desired enzymes can also be used by utilisation of the natural diversitivity. For example, by obtaining enzymes from organisms or metagenomic libraries, which in turn must be tested specifically. Diversitivity can also be established by man by mutagenising existing enzymes and then testing the enzymes obtained for modified substrate specificity. Examples for generating various enzymes by molecular techniques are disclosed in WO-A-2012/069434, where NADP(H)-dependent enzymes for the preparation of n-heterocyclic optically active alcohols are obtained. Similar processes for the preparation of 12α-hydroxysteroid dehydrogenase mutants are also described (EP-A-2 441 771). The preparation of large gene libraries which undergo an analysis with a high throughput comprises cloning of the gene library into replicable expression vectors, transforming of the suitable cells with the resulting vector library and expressing the combinantly obtained genes under conditions under which the detection of the desired activity and the isolation of the vector which codes for the gene of which the product has been detected are facilitated.
The direct test for desired conversion of the educt into the product has hitherto preferably been carried out in microtiter plates with 96, 384 or even 1,536 wells. These plates render possible parallel testing of 96, 384 or 1,536 enzymes. The product of the desired enzyme reaction can be determined directly by chromatography techniques. This method requires the removal of a sample from the 96, 384 or 1,536 wells and chromatographic separation for detection of the reaction products, which can be, for example, alcohols or carbonyl compounds. Needless to say, such a procedure is complex and time-consuming. Indirect tests are therefore often used. The fact that NADP(H) absorbs at 340 nm but NADP does not is thus utilised. The amount of NADP(H) consumed can in principle be determined via this. Alternatively, in the carbonyl reductase-catalysed oxidation of an alcohol the conversion of NADP into NADP(H) can also be measured in this way. In this and comparable reactions, the reduction of the cofactor NADP is determined by the increase in absorption at 340 nm. The intrinsic fluorescence of the reduced cofactor can equally also be used for the quantification. This is effected in microtiter reader apparatuses.
In another method for determining the NADP(H) consumption for detection of the enzymatic reductive transamination and also the reduction of ketones, the change in pH accompanying the NADP(H) consumption is determined by a colour indicator (U.S. Pat. No. 7,642,073). By a suitable choice of the colour indicator the wavelength of the change in colour can be determined, which in turn is determined in microtiter reader apparatuses.
Specific microtiter plate systems in which a screening in the microtiter plate format with up to 1,536 wells is carried out via membranes with specific analyte binding properties and liquid streams are also described (EP-A-1 628 768).
Attempts have also been made to make analytes more easily detectable by coupling with a detectable group, for example of a fluorophore. For this, the analyte is covalently bonded to a fluorescent group before the reaction is carried out. When the reaction is carried out and the analyte is correspondingly reacted, the fluorescence of the fluorescent group should change, for example by splitting off of the group or by a change in the structure of the analyte. The change in fluorescence is then a measure of the conversion of the analyte. A disadvantage of this, however, is that the fluorescent group often influences the reactivity of the analyte. WO-A-2007/131696 describes that by providing a fluorescent dyestuff and a macrocyclic structure in the sample to be investigated and measuring a fluorescence property of the fluorescent dyestuff at two points in time at least, the analyte concentration can be determined. The macrocyclic structure thereby binds the dyestuff and within the concentration range to be investigated for the analyte this displaces the fluorescent dyestuff from the macrocyclic structure.
In the in vitro screening set-ups known from the prior art for isolating new NADP(H)-consuming enzymes or NADP(H)-consuming enzymes from gene libraries having a modified substrate specificity, a general disadvantage is that microtiter plate systems which do not render possible high throughput screening such as is possible, for example, with fluorescence-activated cell sorting (FACS) are used.
Furthermore, in in vitro screening set-ups for isolating new NADP(H)-dependent enzymes, cell lysates are often employed as a potential source of new enzymes, since isolation in the pure form is operationally difficult. The problem of such lysates or preparations in routine screening for new NADP(H)-dependent enzymes is, however, that the reaction batch typically contains insoluble material or other enzymes which interact with the NADP(H). This leads to high blank values or also a modified non-specific absorption at 340 nm, which reduces the accuracy and the value of the absorption measurement. The same applies to fluorescence measurement of the cofactor, which is likewise made difficult by insoluble material.
The present invention was based on the object of overcoming the disadvantages emerging from the prior art in connection with isolating new NADP(H)-dependent enzymes.
In particular, the present invention was based on the object of providing a tool which can be used in order to be able to isolate in a high throughput screening, for example by means of FACS, from a cell suspension in the simplest possible manner those cells which possibly express new NADP(H)-dependent enzymes. In particular, the isolation of these cells should comprise no cell breakdown, and in particular also no analytical determination of the concentration of particular educts, products or cofactors.
The present invention was moreover based on the objet of providing a cell which, after a gene for a potential NADP(H)-dependent enzyme, for example in the form of a plasmid, has been introduced into the cell, can be analysed particularly easily, and in particular without the need for a cell breakdown, as to whether the gene expressed by this cell in fact codes for an NADP(H)-dependent enzyme. A cell identified in this manner should moreover should be able to be separated off as far as possible in a targeted manner in a high throughput screening, for example by means of FACS, from a large number of cells, for example from a cell suspension.
A contribution towards achieving the abovementioned objects is made by an NADP(H) nanosensor comprising
i) a nucleic acid sequence to which a regulator is capable of binding, wherein the oxidation state of the regulator depends on the NADP(H) availability;
ii) a promoter sequence following the nucleic acid sequence i), to which an RNA polymerase is capable of binding, wherein the affinity of the RNA polymerase for the promoter sequence is influenced by the oxidation state of the regulator;
iii) a nucleic acid sequence which is under the control of the promoter sequence ii) and which codes for an autofluorescent protein.
It has been found, surprisingly, that using the NADP(H) nanosensor according to the invention the intracellular NADP or NADP(H) concentration, and therefore indirectly the activity of NADP(H)-dependent enzymes in a cell, can be determined in vivo particularly easily. If a cell containing the NADP(H) nanosensor according to the invention is characterised by a high activity of NADP(H)-dependent enzymes, the concentration of NADP is correspondingly high (and the NADP(H) concentration correspondingly low). Depending on this reduction state of the cell, the regulator is capable of influencing the affinity of the RNA polymerase for the promoter controlling the expression of the autofluorescent protein, or the stability of the mRNA coding for the autofluorescent protein. The expression of the autofluorescent protein is thus controlled according to the reduction state of the cell, and in turn can be monitored in a simple manner by irradiation with electromagnetic radiation, which excites the autofluorescent protein to emission of light. The emission of light by the cells is thus an indicator for the reduction state of the cell and consequently for the extent of the expression of NADP(H)-dependent enzymes.
According to a preferred embodiment of the NADP(H) nanosensor according to the invention, the regulator is the Sox regulator (SoxR) and the promoter sequence is the soxS promoter sequence. The gene for SoxR from E. coli K12 is deposited under accession numbers b4063, ECK4055 in the National Center for Biotechnology Information (NCBI) database of the National Library of Medicine (Bethesda, Md., USA). SoxR contains two [2Fe-2S] clusters, which are essential for the transcription activity. Each SoxR polypeptide contains a [2Fe-2S] cluster which detects the reduction state of the cell. Both Fe-SoxR and apo-SoxR bind to the promoter region, but only Fe-SoxR contributes towards promoter activation in the oxidised form. The redox state of the iron-sulphur cluster regulates the SoxR activity. The target gene of SoxR is the adjacent soxS, the sequence of which is deposited under numbers b4062, ECK4054 in the National Center for Biotechnology Information (NCBI) database of the National Library of Medicine (Bethesda, Md., USA). The reduction state of the cell can be promoted, if appropriate, by NADP(H)-dependent reductases, such as Rsx or RseC.
In this connection it is furthermore preferable for components i) and ii) to be formed by the intergenic region from E. coli, which is located between soxR and soxS and which comprises the SoxR binding sequence, the soxS promoter sequence following the SoxR binding sequence and a sequence following the soxS promoter sequence, which corresponds at the level of the mRNA to a ribosome binding site, or by a nucleic acid sequence homologous to this. Components i) and ii) in this context are preferably formed by a nucleic acid sequence selected from the group consisting of:
a) a nucleic acid sequence according to SEQ. ID. No. 01,
b) a nucleic acid sequence which has an identity of at least 70%, preferably at least 80%, still more preferably at least 85%, still more preferably at least 90%, still more preferably at least 91%, still more preferably at least 92%, still more preferably at least 93%, still more preferably at least 94%, still more preferably at least 95%, still more preferably at least 96%, still more preferably at least 97%, still more preferably at least 98% and most preferably at least 99% to the nucleic acid sequence of a), the nucleic acid sequence being able to bind SoxR such that the affinity of the RNA polymerase for the soxS promoter depends on the oxidation state of SoxR, and
c) a nucleic acid sequence which is capable of hybridising under stringent conditions with a complementary nucleic acid sequence according to a) or b), the nucleic acid sequence being able to bind SoxR such that the affinity of the RNA polymerase for the soxS promoter depends on the oxidation state of SoxR.
According to a first variant of this particularly preferred embodiment of the NADP(H) nanosensor according to the invention, this comprises
(α1) the E. coli gene for SoxR (soxR) or a nucleic acid sequence homologous to this;
(α2) the intergenic region from E. coli, following (α1), which is located between soxR and soxS and which comprises the SoxR binding sequence, the soxS promoter sequence following the SoxR binding sequence and a sequence following the soxS promoter sequence, which at the level of the mRNA corresponds to a ribosome binding site, or a nucleic acid sequence homologous to this, as defined above, as components i) and ii);
(α3) if appropriate a part sequence, following (α2), of the soxS gene from E. coli or a nucleic acid sequence homologous to this;
(α4) a nucleic acid sequence, which codes for an autofluorescent protein, following (α2) or (α3), preferably (α3) and which is under the control of the soxS promoter sequence, as component iii).
The wording “a sequence b) following a sequence a)” as used above and also in the following is to be understood according to the invention as meaning that the sequence b) does not necessarily have to be bonded directly to the sequence a), but that an intermediate sequence can also be located between sequence a) and sequence b).
According to this particular embodiment, the NADP(H) nanosensor comprises as component (α1) the E. coli gene for soxR (soxR) or a nucleic acid sequence homologous to this, component (α1) preferably being selected from the group consisting of:
a) a nucleic acid sequence according to SEQ. ID. No. 02,
b) a nucleic acid sequence coding for a polypeptide with an amino acid sequence according to SEQ. ID. No. 03,
c) a nucleic acid sequence which has an identity of at least 70%, preferably at least 80%, still more preferably at least 85%, still more preferably at least 90%, still more preferably at least 91%, still more preferably at least 92%, still more preferably at least 93%, still more preferably at least 94%, still more preferably at least 95%, still more preferably at least 96%, still more preferably at least 97%, still more preferably at least 98% and most preferably at least 99% to the nucleic acid sequence of a) or b), the nucleic acid sequence coding for a polypeptide which is capable of binding to the SoxR binding sequence in the intergenic region from E. coli which is located between soxR and soxS and the oxidation state thereof being capable of influencing the affinity of the RNA polymerase for the promoter sequence likewise located in the intergenic region from E. coli,
d) a nucleic acid sequence coding for a polypeptide which has a homology of at least 70%, preferably at least 80%, still more preferably at least 85%, still more preferably at least 90%, still more preferably at least 91%, still more preferably at least 92%, still more preferably at least 93%, still more preferably at least 94%, still more preferably at least 95%, still more preferably at least 96%, still more preferably at least 97%, still more preferably at least 98% and most preferably at least 99% to SEQ. ID. No. 03, the nucleic acid sequence coding for a polypeptide which is capable of binding to the SoxR binding sequence in the intergenic region from E. coli which is located between soxR and soxS and the oxidation state thereof being capable of influencing the affinity of the RNA polymerase for the promoter sequence likewise located in the intergenic region from E. coli, and
e) a nucleic acid sequence which is capable of hybridising under stringent conditions with a complementary nucleic acid sequence according to one of groups a) to d), the nucleic acid sequence coding for a polypeptide which is capable of binding to the SoxR binding sequence in the intergenic region from E. coli which is located between soxR and soxS and the oxidation state thereof being capable of influencing the affinity of the RNA polymerase for the promoter sequence likewise located in the intergenic region from E. coli.
The expression “homology” (or “identity”) as used herein can be defined by the equation H (%)=[1−V/X]×100, wherein H denotes homology, X is the total number of nucleobases/amino acids of the comparison sequence and V is the number of different nucleobases/amino acids of the sequence to be considered, with respect to the comparison sequence. In all cases, the term nucleic acid sequences which code for polypeptides includes all sequences which appear to be possible according to the proviso of degeneration of the genetic code.
The identity of nucleic acid sequences can be identified using a sequence comparison program (BLAST, Altschul et al. J. Mol. Biol. 1990, 215, 403-410). The percentage homology between two amino acid sequences can likewise be readily determined by the person skilled in the art using methods know from the prior art. A suitable program which can be employed according to the invention is BLASTp (Altschul et al. 1997; “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”; Nucleic Acids Res. 25(17): 3389-3402).
The person skilled in the art can find instructions for hybridisation inter alia in the handbook “The DIG System User's Guide for Filter Hybridization” of Boehringer Mannheim GmbH (Mannheim, Germany, 1993) and in Liebl et al. (International Journal of Systematic Bacteriology 41: 255-260 (1991)). The hybridisation takes place under stringent conditions, that is to say only hybrids in which the probe, for example the nucleotide sequence complementary to soxR or soxS or the intergenic region of soxRS from E. coli, and the target sequence, i.e. the polynucleotides treated with the probe, are at least 70% identical. It is known that the stringency of the hybridisation including the washing steps is influenced or determined by varying the buffer composition, the temperature and the salt concentration. The hybridisation reaction is in general carried out at a relatively low stringency compared with the washing steps (Hybaid Hybridisation Guide, Hybaid Limited, Teddington, U K, 1996). For the hybridisation reaction, for example, a buffer corresponding to 5×SSC buffer can be employed at a temperature of approx. 50° C.-68° C. In this context probes can also hybridise with polynucleotides which have less than 70% identity to the sequence of the probe. Such hybrids are less stable and are removed by washing under stringent conditions. This can be achieved, for example, by lowering the salt concentration to 2×SSC and if appropriate subsequently 0.5×SSC (The DIG System User's Guide for Filter Hybridization, Boehringer Mannheim, Mannheim, Germany, 1995), a temperature of approx. 50° C.-68° C., approx. 52° C.-68° C., approx. 54° C.-68° C., approx. 56° C.-68° C., approx. 58° C.-68° C., approx. 60° C.-68° C., approx. 62° C.-68° C., approx. 64° C.-68° C., approx. 66° C.-68° C. being established. Preferably, the washing steps are carried out at temperatures of approx. 62° C.-68° C., preferably of 64° C.-68° C. or approx. 66° C.-68° C., particularly preferably of approx. 66° C.-68° C. It is possible, where appropriate, to lower the salt concentration to a concentration corresponding to 0.2×SSC or 0.1×SSC. By increasing the hybridisation temperature stepwise in steps of approx. 1-2° C. from 50° C. to 68° C., polynucleotide fragments which code for soxR or soxS or the intergenic region of soxRS which have, for example, at least 70% or at least 80% or at least 90% to 95% or at least 96% to 98% or at least 99% identity to the sequence of the probe employed can be isolated. Further instructions for the hybridisation are obtainable on the market in the form of so-called kits (e.g. DIG Easy Hyb from Roche Diagnostics GmbH, Mannheim, Germany, catalogue no. 1603558).
The NADP(H) nanosensor according to this particular embodiment comprises as component (α4) a nucleic acid sequence which codes for an autofluorescent protein and which follows (α2) or α3), preferably the target gene soxS (α3), in particular the first 5 to 200 nucleotides of the target gene soxS, and is under the control the soxS promoter sequence, as component iii).
According to the invention, the gene sequence according to component iii) coding for the autofluorescent protein is under the control of the promoter sequence ii) (according to the first variant described above for the particular embodiment of the NADP(H) nanosensor according to the invention, the gene sequence (α4) coding for the autofluorescent protein is under the control of the soxS promoter sequence). The term “under the control of the promoter sequence” in this context is preferably to be understood as meaning that the gene sequence coding for the autofluorescent protein is functionally linked to the promoter. The promoter and the gene sequence coding for the autofluorescent protein are functionally linked if these two sequences and optionally further regulative elements, such as, for example, a terminator or a ribosome binding site, are arranged sequentially such that each of the regulative elements can fulfil its function in the transgenic expression of the nucleic acid sequence. For this, a direct linking in the chemical sense is not absolutely necessary. Genetic control sequences, such as, for example, enhancer sequences, can also exert their function on the target sequence from further removed positions or even from other DNA molecules. Arrangements in which the gene sequence coding for the autofluorescent protein is positioned after the promoter sequence (i.e. at the 3′ end), so that the two sequences are bonded covalently to one another, are preferred. Preferably, in this context the distance between the gene sequence coding for the autofluorescent protein and the promoter sequence is less than 200 base pairs, particularly preferably less than 100 base pairs, very particularly preferably less than 50 base pairs. It is also possible for the gene sequence coding for the autofluorescent protein and the promoter to be linked functionally to one another such that there is still a part sequence of the homologous gene (that is to say that gene of which the expression in the wild-type cell is regulated by the promoter) between these two gene sequences (according to the particular embodiment of the NADP(H) nanosensor described above, parts of the soxS gene according to component (α3) can accordingly be between the soxS promoter sequence and the nucleic acid sequence (α4) coding for the autofluorescent protein). In the expression of such a DNA construct, a fusion protein is obtained from the autofluorescent protein and the amino acid sequence which is coded by the corresponding part sequence of the homologous gene (=translational fusion). The lengths of such part sequences of the homologous gene are not critical as long as the functional capacity of the autofluorescent protein, that is to say its property of being fluorescent when excited with light of a particular wavelength, is not noticeably impaired. In the case of the particular embodiment of the NADP(H) nanosensor according to the invention described above, the soxS part sequence (α3) preferably comprises at least the first 5 nucleotides, still more preferably at least the first 10 nucleotides and still more preferably at least the first 20 nucleotides, but preferably at most the first 200 nucleotides, still more preferably at most the first 150 nucleotides and still more preferably at most the first 100 nucleotides of the soxS gene.
The nucleic acid sequence (iii) (or (α4) and (β4)) coding for an autofluorescent protein preferably comprises genes coding for fluorescent proteins which code for fluorescent proteins of the genus Aequora, such as green fluorescent protein (GFP), and variants thereof which are fluorescent in a different wavelength range (e.g. yellow fluorescent protein (YFP), blue fluorescent protein (BFP), cyan fluorescent protein (CFP)) or of which the fluorescence is enhanced (e.g. enhanced green fluorescent protein (EGFP), enhanced yellow fluorescent protein (EYFP), enhanced blue fluorescent protein (EBFP) or enhanced cyan fluorescent protein (ECFP). Gene sequences which code for other autofluorescent proteins, e.g. DsRed, HcRed, AsRed, AmCyan, ZsGreen, AcGFP, ZsYellow, such as are known from BD Biosciences, Franklin Lakes, USA, can furthermore also be used according to the invention. A photoreceptor protein which contains a so-called LOV domain can likewise be used. The particularly preferred autofluorescent protein in this context is EYFP.
According to a second variant of the particularly preferred embodiment of the NADP(H) nanosensor according to the invention, this comprises
(β1) the E. coli gene for SoxR (soxR) or a nucleic acid sequence homologous to this;
(β2) the intergenic region from E. coli, following (β1), which is located between soxR and soxS and which comprises the SoxR binding sequence, the soxS promoter sequence following the SoxR binding sequence and a sequence following the soxS promoter sequence which at the level of the mRNA corresponds to a ribosome binding site, or a nucleic acid sequence homologous to this, as defined above, as components i) and ii);
(β3) the sequence of the soxS gene from E. coli following (β2) and under the control of the soxS promoter sequence, a part sequence of this gene or a nucleic acid sequence homologous to this;
(β3′) a further sequence following (β3) which at the mRNA level corresponds to a ribosome binding site;
(β4) a nucleic acid sequence, which codes for an autofluorescent protein, following (β3′) and which is under the control of the soxS promoter sequence, as component iii).
Components (β1), (β2, (β3) and (β4) which are preferred are those components which have already been mentioned above as preferred components (α1), (α2), (α3) and (α4) in connection with the first variant of the particularly preferred embodiment of the NADP(H) nanosensor according to the invention, During the expression of such a DNA construct, SoxS or a fragment of this protein and, separately from this, the autofluorescent protein are formed (=transcriptional fusion).
A contribution towards achieving the abovementioned objects is also made by a cell comprising an NADP(H) nanosensor according to the invention. In this context the NADP(H) nanosensor according to the invention can be present in the cell in the episomal or chromosomal form.
Examples of suitable cells which may be mentioned in particular are Escherichia coli, Pseudomonas fluorescens, Corynebacterium glutamicum, Bacillus subtilis or another Eubacterium, or also Saccharomyces cerevisiae or another yeast.
The cells according to the invention are suitable for establishing whether particular gene sequences code for an NADP(H)-dependent enzyme. For this, the gene coding for a potential NADP(H)-dependent enzyme is introduced into the cell and expressed. As described above, the emission of light by the cells is an indicator for the reduction state of the cell and consequently for the extent of the expression of NADP(H)-dependent enzymes.
In this context, according to the invention an “NADP(H)-dependent enzyme” is understood as meaning any enzyme which is involved in at least a part step of the conversion of a substrate into a reaction product which is chemically different from this substrate, NADP(H) being involved as a cofactor in at least one part step of this conversion.
According to a preferred embodiment of the cell according to the invention, this accordingly furthermore comprises, in addition to the NADP(H) nanosensor according to the invention, a plasmid with an optionally mutated gene which codes for an NADP(H)-dependent enzyme. The NADP(H)-dependent enzyme in this context is preferably selected from the group consisting of alcohol dehydrogenases, aldehyde dehydrogenases, lactate dehydrogenases, enoate reductases, epoxide reductases, diaminopimelate dehydrogenases, amino acid dehydrogenases, aldehyde oxidoreductases, alkane reductases, amine reductases, epoxide dehydrogenases, carboxylic acid dehydrogenases, hydroxy acid ketoreductases and hydroxy acid dehalogenases.
A contribution towards achieving the abovementioned objects is also made by a recombinant cell comprising a nucleic acid sequence coding for an autofluorescent protein, wherein the extent of the expression of the autofluorescent protein in the cell depends on the intracellular NADP(H) availability. In this connection particularly preferred cells are the cells described above, in particular cells comprising the NADP(H) sensor according to the invention.
A contribution towards achieving the abovementioned objects is also made by a method for isolating genes which code for NADP(H)-dependent enzymes, comprising the method steps:
(I) providing an NADP(H) nanosensor according to the invention;
(II) introducing the NADP(H) nanosensor into a cell;
(III) introducing a gene which may code for an NADP(H)-dependent enzyme into individual cells of a cell suspension of the cells obtained in method step (II);
(IV) incubating the cells with a substrate for the NADP(H)-dependent enzyme;
(V) identifying individual cells in the cell suspension with an increased activity of NADP(H)-dependent enzymes by detection of the intracellular fluorescence activity;
(VI) separating off the identified cells from the cell suspension;
(VII) isolating the genes coding for an NADP(H)-dependent enzyme in the identified cells.
New NADP(H)-dependent enzymes and mutated NADP(H)-dependent enzymes with increased or modified substrate recognition can be isolated with the aid of this method.
Sensors and cells which are preferred as the NADP(H) sensor and as the cell are those which have already been described above as preferred sensors or cells in connection with the sensor according to the invention or the cell according to the invention.
In method steps (I) and (II) a cell according to the invention is first prepared by introducing the NADP(H) nanosensor according to the invention into a cell, it being possible for this introduction to be carried out in the episomal or chromosomal form.
In method step (III) of the method according to the invention a gene which may code for an NADP(H)-dependent enzyme is then introduced into individual cells of a cell suspension of the cells obtained in method step (II), it being possible for the gene to be, in particular, a mutated, plasmid-coded gene of an NADP(H)-dependent enzyme. To introduce the site-nonspecific mutations into the plasmid-coded genes of the NADP(H)-dependent enzymes to increase the diversity, an in vitro mutagenesis is preferably carried out with the aid of an error-prone polymerase chain reaction (PCR) and an amplification technique. In this context the gene to be mutated is subjected to a PCR using a polymerase which, depending on the conditions of the reaction, incorporates individual bases incorrectly into the synthesized genes (Tindall, K. R. and T. A. Kunkel: “Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase”; Biochemistry, 1988, 27 (16), pages 6008-13). A frequent variant of this method comprises the use of manganese (II) ions or of nucleotide analogues in the PCR batch (Cadwell R. C et al. (1992); PCR Methods Appl. (2), pages 28-33/Leung D. W. et al. (1989) Techniques (1), pages 11-15). These techniques for introduction of mutations are called “error-prone PCR (epPCR)” (Labrou NE: “Random mutagenesis methods for in vitro directed enzyme evolution”; Curr. Protein. Pept. Sci. 2010 (11), pages: 91-100). The mutations can be, for example, point mutations, and e.g. substitutions, deletions or insertions can be generated by the polymerase. The mutation rate is between 1-40 mutations per 1 kb, preferably 1-5 mutations per 1 kb. However, mutations can also be produced with the aid of saturation mutagenesis using the Stratagene QuikChange Kit (La Jolla, Calif., USA), or also using a method called SeSam (EP 1 670 914 B1), with which any existing nucleotide is transferred under saturation into any possible nucleotide.
Possible NADP(H)-dependent enzymes of which the activity can be analysed with the nanosensor-carrying host in a high throughput are, for example, 1,2-dehydroreticulin reductases (1.5.1.27), 2-enoyl-CoA reductase (1.3.1.10), 2-enoyl-CoA reductases (1.3.1.39), alkenal/one oxidoreductases (1.3.1.74) cytochrome P450 reductase (1.6.2.4), NADP(H) dehydrogenases (1.6.99.1), NADP(H) dehydrogenases (flavin) (1.6.8.2), NADP(H) dehydrogenases (quinone) (1.6.5.10), NADP(H)-dependent 1,5-anhydro-D-fructose reductases (1.1.1.263), NADP(H)-dependent cytochrome P450 reductases (1.6.2.4), diaphorases (1.6.99.1), DT-diaphorases (1.6.5.5), ferredoxin reductases (1.18.1.2), NADP(H) oxidases (1.6.3.1, 1.6.5.10, 1.6.3.1, 1.6.3.1, 1.6.3.1), P450 oxidoreductase (1.6.2.4), P450 reductase (1.6.2.4), peroxidase (1.11.1.2), quinone acceptor oxidoreductase (1.6.5.5), quinone oxidoreductase (1.6.5.10), NADP(H)-specific FMN reductase (1.5.1.38), thioredoxin reductase (1.8.1.9), transhydrogenase (1.6.1.2), NADP(H)-aldehyde reductase (1.1.1.2), aldopentose reductase (1.1.1.21), NADP(H)-aldose reductase (1.1.1.21), NADP(H)-carbonyl reductase (1.1.1.184), NADP(H)-CYP reductase (1.6.2.4), NADP(H)-cytochrome c oxidoreductase (1.6.2.4), NADP(H)-cytochrome c reductase (1.1.1.2), NADP(H)-cytochrome f reductase (1.6.2.5), NADP(H)-cytochrome P450 reductase (1.6.2.4) and NADP(H)-cytochrome P450 reductase (1.14.13.68).
The plasmids which contain mutations in genes of the NADP(H)-dependent enzymes are then introduced into the microorganism, such as, for example, E. coli or C. glutamicum, by transformation. In this context the term “transformation” includes all methods for transfer of polynucleotides, in particular DNA, into a desired bacterium. These include inter alia the use of isolated DNA in transformation, electro transformation or electroporation, transfer by cell contact, as in conjugation, or transfer of DNA by means of particle bombardment.
After in process step (III) a gene which optionally codes for an NADP(H)-dependent enzyme has been introduced into individual cells of a cell suspension from the cells obtained in method (II) (and expressed), the cells are then incubated in method step (IV) with a substrate for an NADP(H)-dependent enzyme, and in method step (V) individual cells in the cell suspension with an increased activity of NADP(H)-dependent enzymes are then identified by detection of the intracellular fluorescence activity. For this, the cell suspension is exposed to electromagnetic radiation in that frequency which excites the autofluorescent protein of the NADP(H) nanosensor to emission of light.
In method step (VI) the identified cells are then separated off from the cell suspension, this separating off preferably being carried out by means of flow cytometry (FACS=fluorescence activated cell sorting), very particularly preferably by means of high throughput flow cytometry (HT-FACS=high throughput fluorescence activated cell sorting). Details on the analysis of cell suspensions by means of flow cytometry can be found, for example, in Sack U, Tarnok A, Rothe G (eds.): Zellulare Diagnostik. Grundlagen, Methoden und klinische Anwendungen der Durchflusszytometrie, Basel, Karger, 2007, pages 27-70.
In method step (VII) the genes coding for an NADP(H)-dependent enzyme in the identified cells are then isolated and if appropriate analysed, for example by isolating the enzyme-carrying plasmids from the cells which have been separated off and identifying and verifying, by sequencing, their mutation which lead to modified fluorescence.
A contribution towards achieving the abovementioned objects is also made by the use of the NADP(H) nanosensor according to the invention for identifying, in vivo, genes which code for an NADP(H)-dependent enzyme.
The invention is now explained in more detail with the aid of figures and non-limiting examples.
According to
With the primer pairs SoxS_for_SphI (SEQ. ID. No. 04) and SoxR_rev_SalI (SEQ. ID. No. 05) and chromosomal DNA from E. coli DH5α as the template, the gene soxR was amplified together with the intergenic region of soxR-soxS and the first 63 nucleotides of soxS.
With the primer pairs EYFP_for_SphI (SEQ. ID. No. 06) and EYFP_rev_ClaI (SEQ. ID. No. 07) and the vector pSenLys as the template, the gene eyfp was amplified together with a ribosome binding site. The vector pSenLys is described in the patent application WO-A-2011/138006.
The vector pBtacLbadh codes for the NADPH-dependent alcohol dehydrogenase from Lactobacillus brevis (Lbadh). It is described in Ernst et al. (Ernst M, Kaup B, Müller M, Bringer-Meyer S, Sahm H, Appl. Microbiol. Biotechnol. 2005, 66(6), pages 629-34). The vector pBtacLbadh was treated with the restriction enzymes SalI and ClaI, and the vector fragment ˜5.0 kb in size was isolated from the agarose gel and treated with alkaline phosphatase and purified with the QIAquick Gel Extraction Kit (cat. no. 28704) from Quiagen (Hilden, Germany). The two PCR products and the vector were then ligated by means of T4 DNA ligase from New England BioLabs (New England Biolabs, 240 County Road, Ipswich, Mass. 01938-2723). The ligation batch was transformed directly into the E. coli strain DH5α. Selection of plasmid-carrying cells was carried out by plating out the transformation batch on LB agar (Sambrook et al.: “Molecular cloning: a laboratory manual”, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.), which had been supplemented with 50 mg/l of ampicillin. Plasmid DNA was isolated from a transformant and checked by treatment with the restriction enzyme BamHI with subsequent agarose gel electrophoresis. The plasmid was called pSenSox and is deposited as the sequence SEQ. ID. No. 08.
pSennegK was created as a derivative with modified alcohol dehydrogenase, Lbadh. For this, with the primers ADH_negK_for (SEQ. ID. No. 09) and ADH_negK_rev (SEQ. ID. No. 10) and again pBtacLbadh as the template, an inactive Lbadh was amplified with an alcohol dehydrogenase deleted by 221 bp. The resulting fragment was ligated with the ˜5.7 kb size vector fragment containing the gene eyfp together with a ribosome binding site. The sequence of the resulting vector is deposited as SEQ. ID. No. 11.
pSen-L194S was created as a further derivative with modified alcohol dehydrogenase, Lbadh. For this, with the primers L194S_for (SEQ. ID. No. 12) and L194S_rev (SEQ. ID. No. 13), pSenSox was amplified as a template for targeted insertion of the mutation. The plasmid generated was verified by means of sequencing. The sequence of the resulting vector is deposited as SEQ. ID. No. 14.
pSen-L194A was created as a further derivative with modified alcohol dehydrogenase, Lbadh. For this, with the primers L194A_for (SEQ. ID. No. 15) and L194A_rev (SEQ. ID. No. 16), pSenSox was amplified as a template for targeted insertion of the mutation. The plasmid generated was verified by means of sequencing. The sequence of the resulting vector is deposited as SEQ. ID. No. 17.
E. coli BL21(DE3) (Life Technologies GmbH, Frankfurter Straβe 129B, 64293 Darmstadt) was transformed with the plasmid pSenSox. 5 ml of 2×YT medium (16 g/l of tryptone, 10 g/l of yeast extract, 5 g/l of NaCl) was inoculated with an individual colony and the culture was incubated overnight at 37° C. and 130 rpm. Using this preculture the main culture was inoculated to an OD of 0.05 in 50 ml of 2×TY and was incubated at 37° C. and 130 rpm. At the OD of 0.3 1 mM IPTG was added and the culture was incubated for a further 3 hours to an OD of 5-6.
0.9 ml portions of the cell suspension were then introduced into a reaction vessel of the Flowerplate microtiter plate (48-well) of the BioLector cultivation system (m2plabs GmbH, Aachen, Germany). Methyl acetoacetate (MAA) was added to the cell suspension in increasing concentration in a constant volume of 0.1 ml. The Flowerplate microtiter plate was then incubated at 30° C., 1,200 rpm, shaking radius 3 mm. In the BioLector cultivation system the growth was recorded online as scattered light at 620 nm, and the fluorescence of the culture was recorded continuously at an excitation wavelength of 485 nm and an emission wavelength of 520 nm. The specific fluorescence after 10 hours was plotted against the amount of MAA added and is shown in
The strain E. coli BL21(DE3) (Life Technologies GmbH, Frankfurter Straβe 129B, 64293 Darmstadt) was transformed in each case with pSennegK, pSen-L194S and pSen-L194A. In addition, the strain E. coli BL21(DE3) pSenSox described in Example 2 was transformed with pET28a as the second plasmid. The vector mentioned last was obtained from Novagen (Life Technologies GmbH, Frankfurter Straβe 129B, 64293 Darmstadt). 5 ml of 2×YT medium (16 g/l of tryptone, 10 g/l of yeast extract, 5 g/l of NaCl) was inoculated with an individual colony of the particular strain and the culture was incubated overnight at 37° C. and 130 rpm. Using this preculture the main culture was inoculated to an OD of 0.05 in 50 ml of 2×TY and was incubated at 37° C. and 130 rpm. At the OD of 0.3 no IPTG was added or 1 mM IPTG was added to the strain E. coli BL21(DE3) pSenSox and the culture was incubated for a further 3 hours to an OD of 5-6.
As described in Example 2, 0.9 ml portions of the cells were then each introduced into a reaction vessel of the Flowerplate microtiter plate (48-well) of the BioLector cultivation system (m2plabs GmbH, Aachen, Germany). Methyl acetoacetate (MAA) was in each case added, in 0.1 ml, to the cell suspension to a final concentration of 40 mM. The Flowerplate microtiter plate was then incubated at 30° C., 1,200 rpm, shaking radius 3 mm, and the specific fluorescence was determined. The specific fluorescence obtained after 19 hours is shown in Table 1.
In addition, the alcohol dehydrogenase activity of the recombinant E. coli cells was determined in the individual batches. For this, the cells were harvested at 10,000×g, 4° C., 5 min and taken up in 100 mM potassium phosphate buffer, pH 6.5, 1 mM dithiothreitol, 1 mM MgCl2. The cells were broken down by means of the Silamat S5 (Ivoclar Vivadent GmbH, Germany) with the aid of glass beads of 0.1 mm diameter. The crude extract which was obtained after centrifugation at 16,000×g, 4° C., 20 min was employed in the enzyme test for quantification of the alcohol dehydrogenase activity. The test contained 5 mM methyl acetoacetate, 0.25 mM NADPH and 1 mM MgCl2 in 100 mM potassium phosphate buffer, pH 6.5, and 0.01-0.1 ml of crude extract. The reduction of NADP(H) was monitored at 340 nm and 30° C. An enzyme unit (U) is stated as that amount of crude extract which reduces 0.001 mmol of NADP(H) per minute. It is likewise given in Table 1.
Isolation of Mutated Alcohol Dehydrogenase with Modified Substrate Recognition
The alcohol dehydrogenase Lbadh from Lactococcus lactis has a high activity with methyl acetoacetate, but only a low activity of about 10% with 4-methyl-2-pentanone as the substrate. In order to evolve an Lbadh with a higher activity, random mutations were inserted into pSenSox by error-prone PCR (epPCR). To insert the mutations, 10 ng of pSenSox were employed as the template per reaction, as well as 0.1-0.8 mM Mn2+, at the lower concentrations of below <0.2 mM Mn2+ a total concentration of at least 0.2 mM being established with Mg2+. 0.5 μl of Taq polymerase from Fermentas (catalogue no. EP0401) was added per reaction. The polynucleotides
were used as primers. The reactions were incubated for 30 minutes. The reaction products were then treated with BamHI and SalI and ligated with the vector pSenSox likewise treated beforehand.
E. coli DH5αmcr was transformed with the ligation products (Grant, 1990, Proceedings of the National Academy of Sciences, USA, 87, pages 4645-4649). After incubation for 30 h, transformants were washed off from the plates with 10 ml of 2×YT and diluted tenfold in fresh 2×YT medium. After incubation for 4 hours at 37° C., 20 mM 4-methyl-2-pentanone was added as the substrate, and after a further incubation for three hours the batches were sent for FACS analysis and sorting.
For FACS analysis and sorting of the cells with high fluorescence, the cell suspension in 2×YT medium was adjusted to an optical density of less than 0.1 and passed immediately to the FACS ARIA II high-speed cell sorter (Becton Dickinson GmbH, Tullastr. 8-12, 69126 Heidelberg). The analysis was carried out with the excitation wavelengths of 488 and 633 nm and the detection at the emission wavelengths of 530±15 nm and 660±10 nm under a sample pressure of 70 psi. The data were analysed with the software version BD DIVA 6.1.3 belonging to the apparatus. BD FACSflow was used as the sheath fluid. The electronic gating was set with the aid of the forward and backward scatter in order to exclude non-bacterial particles. In order to sort EYFP-positive cells, the next level of the electronic gating was selected, in order to exclude non-fluorescent cells. In this manner, 123 fluorescent cells were sorted out on Petri dishes which contained 2×YT medium.
Reaction vessels of the Flowerplate microtiter plate (48-well) of the BioLector cultivation system (m2plabs GmbH, Aachen, Germany) were inoculated, as described in Example 2, with the colonies obtained after incubation for 30 hours at 37° C. However, 20 mM 4-methyl-2-pentanone and not methyl acetoacetate was used as the substrate. After 120 minutes the specific fluorescence was quantified, and a clone was selected, the alcohol dehydrogenase activity of which was determined in the enzyme test as described in Example 3. 20 mM 4-methyl-2-pentanone was used as the substrate here.
The mutant with the plasmid pSen-A93M obtained in this way has a specific activity increased by 26% compared with the starting strain (Table 2), and a conversion rate with 4-methyl-2-pentanone as the substrate increased by 37%. The sequence of the plasmid pSen-A93M is deposited as SEQ. ID. No. 20.
With the primer pairs SoxS_for_SphI_tl (SEQ. ID. No. 21) and SoxR_rev_SalI_tl (SEQ. ID. No. 22) and chromosomal DNA from E. coli DH5α as the template, the gene soxR was amplified together with the intergenic region of soxR-soxS and the first 63 nucleotides of soxS.
With the primer pairs EYFP_for_SphI_tl (SEQ. ID. No. 23) and EYFP_rev_ClaI_tl (SEQ. ID. No. 24) and the vector pSenLys as the template, the gene eyfp was amplified. The vector pSenLys is described in the patent application WO-A-2011/138006.
The vector pBtacLbadh codes for the NADPH-dependent alcohol dehydrogenase from Lactobacillus brevis (Lbadh). It is described in Ernst et al. (Ernst M, Kaup B, Miller M, Bringer-Meyer S, Sahm H, Appl. Microbiol. Biotechnol. 2005, 66(6), pages 629-34). The vector pBtacLbadh was treated with the restriction enzymes SalI and ClaI, and the vector fragment ˜5.0 kb in size was isolated from the agarose gel and treated with alkaline phosphatase and purified with the QIAquick Gel Extraction Kit (cat. no. 28704) from Quiagen (Hilden, Germany). The two PCR products and the vector were then ligated by means of T4 DNA ligase from New England BioLabs (New England Biolabs, 240 County Road, Ipswich, Mass. 01938-2723). The ligation batch was transformed directly into the E. coli strain DH5α. Selection of plasmid-carrying cells was carried out by plating out the transformation batch on LB agar (Sambrook et al.: “Molecular cloning: a laboratory manual”, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.), which had been supplemented with 50 mg/l of ampicillin. Plasmid DNA was isolated from a transformant and checked by treatment with the restriction enzyme BamHI with subsequent agarose gel electrophoresis. The plasmid was called pSenSox_tl and is deposited as the sequence SEQ. ID. No. 25.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10 2012 017 026.2 | Aug 2012 | DE | national |
This application is Divisional of U.S. application Ser. No. 14/424,559 filed Feb. 27, 2015, which is a National Stage application of PCT/EP2013/002481 filed Aug. 16, 2013, which claims priority to German Patent Application No. 10 2012 017 026.2 filed Aug. 28, 2012, the entire disclosures of which are hereby incorporated by reference.
| Number | Date | Country | |
|---|---|---|---|
| 20200027049 A1 | Jan 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14424559 | Feb 2015 | US |
| Child | 16518544 | US |
